About Fructose-bisphosphate aldolase C
Fructose-bisphosphate aldolase C (ALDOC) is a protein
from Homo sapiens identified by UniProt accession
P09972, 364 residues long.
MolForge cross-references it against 0 known binders and
112 disease associations.
Target properties
| Protein name | Fructose-bisphosphate aldolase C |
| UniProt accession | P09972 |
| Gene | ALDOC |
| Organism | Homo sapiens |
| Length | 364 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (112)
Diseases linked to this target (Open Targets).
- blood protein measurement · score 0.10
- glioblastoma multiforme · score 0.08
- non-small cell lung carcinoma · score 0.08
- breast cancer · score 0.08
- melanoma · score 0.08
- hypertriglyceridemia 2 · score 0.06
- glioblastoma · score 0.06
- cholesterol-ester transfer protein deficiency · score 0.06
- hyperlipidemia due to hepatic triglyceride lipase deficiency · score 0.05
- homozygous familial hypercholesterolemia · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P09972-F1 | alphafold | PREDICTED | 96.26 | — |
Amino-acid sequence (364 residues)
MPHSYPALSA EQKKELSDIA LRIVAPGKGI LAADESVGSM AKRLSQIGVE NTEENRRLYR QVLFSADDRV KKCIGGVIFF HETLYQKDDN GVPFVRTIQD KGIVVGIKVD KGVVPLAGTD GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKISERTPS ALAILENANV LARYASICQQ NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HVYLEGTLLK PNMVTPGHAC PIKYTPEEIA MATVTALRRT VPPAVPGVTF LSGGQSEEEA SFNLNAINRC PLPRPWALTF SYGRALQASA LNAWRGQRDN AGAATEEFIK RAEVNGLAAQ GKYEGSGEDG GAAAQSLYIA NHAY
Explore Fructose-bisphosphate aldolase C with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets